Article
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer.
Anti-cancer drugs - 1 Nov 2016
Romiti Adriana, Roberto Michela, D'Antonio Chiara, Onesti Concetta E, Barucca Viola, Milano Annalisa, Gentile Giovanna, Lionetto Luana, Medda Emanuela, Mazzuca Federica, Botticelli Andrea, Falcone Rosa, Simmaco Maurizio, Marchetti Paolo
Abstract excerpt
Low doses of drugs delivered at close, regular intervals are increasingly being used to manage patients with different neoplasms. Despite the good tolerability, treatment-related adverse events still occur following metronomic protocols. The aim of this study was to retrospectively investigate whether polymorphisms of different genes involved in fluoropyrimidine metabolism and 5-fluorouracil (5-FU) degradation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
